GAMCO Investors’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.86M | Sell |
128,800
-14,000
| -10% | -$202K | 0.02% | 544 |
|
|
2025
Q1 | $985K | Buy |
142,800
+1,800
| +1% | +$12.4K | 0.01% | 570 |
|
|
2024
Q4 | $748K | Sell |
141,000
-2,150
| -2% | -$11.4K | 0.01% | 630 |
|
|
2024
Q3 | $522K | Sell |
143,150
-90,000
| -39% | -$329K | 0.01% | 689 |
|
|
2024
Q2 | $637K | Sell |
233,150
-30,700
| -12% | -$83.8K | 0.01% | 666 |
|
|
2024
Q1 | $918K | Buy |
263,850
+2,200
| +0.8% | +$7.66K | 0.01% | 601 |
|
|
2023
Q4 | $374K | Buy |
261,650
+1,800
| +0.7% | +$2.57K | ﹤0.01% | 724 |
|
|
2023
Q3 | $379K | Buy |
259,850
+54,500
| +27% | +$79.6K | ﹤0.01% | 710 |
|
|
2023
Q2 | $322K | Buy |
205,350
+28,800
| +16% | +$45.2K | ﹤0.01% | 741 |
|
|
2023
Q1 | $270K | Buy |
+176,550
| New | +$270K | ﹤0.01% | 787 |
|